Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Lilly trial shows weight loss with experimental pill flattens over time

Summary by CNBC
Eli Lilly's Nexperimental GLP-1 pill helped people lose about 12% of their body weight, with weight loss plateauing for most patients in the 72-week trial, according to full study results presented at a medical meeting on Tuesday.

1 Articles

CNBCCNBC
Center

Lilly trial shows weight loss with experimental pill flattens over time

Eli Lilly's Nexperimental GLP-1 pill helped people lose about 12% of their body weight, with weight loss plateauing for most patients in the 72-week trial, according to full study results presented at a medical meeting on Tuesday.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

CNBC broke the news in United States on Wednesday, September 17, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Eli Lilly icon

Eli Lilly

United States icon

United States

News
For You
SearchBlindspotLocal